Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

Publisher： Karger

E-ISSN： 1421-9794|51|1|36-66

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.1, 2005-04, pp. : 36-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibiotic-Associated Diarrhea and Pseudomembranous Colitis: Are They Less Common with Poorly Absorbed Antimicrobials?

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 81-89

Karger

Access to resources Recommend Favorite

Rifaximin, a Peculiar Rifamycin Derivative: Established and Potential Clinical Use Outside the Gastrointestinal Tract

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 122-130

Karger

Access to resources Recommend Favorite

Microsomes, Drug Oxidation, and Clinical Pharmacology

By  

Skin Pharmacology and Physiology, Vol. 11, Iss. 1, 1998-04 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

Clinical Pharmacology of Furosemide in Neonates: A Review

By Pacifici Gian Maria  

Pharmaceuticals, Vol. 6, Iss. 9, 2013-09 ,pp. : 1094-1129

MDPI

Access to resources Recommend Favorite

Crataegus pinnatifida: Chemical Constituents, Pharmacology, and Potential Applications

By Wu Jiaqi   Peng Wei   Qin Rongxin   Zhou Hong  

Molecules, Vol. 19, Iss. 2, 2014-01 ,pp. : 1685-1712

MDPI

Access to resources Recommend Favorite